Clinical Trial Update: Alendronate in Juvenile Osteoporosis

View source ↗

Summary

This clinical trial update reports completion of a study evaluating alendronate for juvenile osteoporosis and low bone density, with results posted in December …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Osteoporosis
• Osteopenia

Drugs mentioned

• FOSAMAX (ALENDRONATE SODIUM)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Juvenile Osteoporosis, Low Bone Density | Status: COMPLETED | Results posted: 2010-12-10